Skip to main content

Cervical Degenerative Disc Disorder

0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Globus Medical
Globus MedicalAUDUBON, PA
3 programs
Simplify DiscN/A1 trial
Simplify DiscN/A1 trial
Simplify DiscN/A1 trial
Active Trials
NCT04980378Completed291Est. Jan 2024
NCT03123549Completed182Est. Mar 2022
NCT04630626Completed145Est. Apr 2023
NuVasive
NuVasiveCA - San Diego
3 programs
Simplify DiscN/A
Simplify DiscN/A
Simplify DiscN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Globus MedicalSimplify Disc
Globus MedicalSimplify Disc
Globus MedicalSimplify Disc

Clinical Trials (3)

Total enrollment: 618 patients across 3 trials

Post Approval Study Protocol for the Two Level Simplify® Cervical Artificial Disc

Start: Aug 2021Est. completion: Jan 2024291 patients
N/ACompleted

Post-Approval Study Protocol for the Simplify Cervical Artificial Disc

Start: Jan 2021Est. completion: Apr 2023145 patients
N/ACompleted

Investigation of the Two Level Simplify® Cervical Artificial Disc

Start: Apr 2017Est. completion: Mar 2022182 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.